Opendata, web and dolomites
Horizon2020 projects coordinated by "ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM"
| # | ||||
|---|---|---|---|---|
| 1 | METAFLEX Metabolic flexibility: breaking down food effectively to prolong life | 2015 | 1˙499˙446.00 | 1˙499˙446.00 |
| 2 | CRCSTEMCELLDYNAMICS Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers | 2015 | 1˙499˙875.00 | 1˙499˙875.00 |
| 3 | COORDINATEDDOPAMINE Coordination of regional dopamine release in the striatum during habit formation and compulsive behaviour | 2015 | 1˙500˙000.00 | 1˙500˙000.00 |
| 4 | INFLAMMOSTROME Stromal cells as primary drivers of immunopathology: towards targeted disease modification in spondyloarthritis | 2015 | 1˙599˙466.00 | 1˙599˙466.00 |
| 5 | SENTINEL HIV-1 sensing and signaling in dendritic cells | 2015 | 2˙499˙156.00 | 2˙499˙156.00 |
| 6 | SILNE-R Enhancing the effectiveness of programs and strategies to prevent youth smoking: a comparative realist evaluation of 7 European cities | 2015 | 2˙999˙997.00 | 2˙999˙997.00 |
| 7 | HAAIV Adaptive evolutionary pathways of highly pathogenic avian H5N1 influenza in humans | 2015 | 177˙598.00 | 177˙598.00 |
| 8 | REPROGRAM Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases | 2016 | 6˙000˙000.00 | 5˙250˙000.00 |
| 9 | AFFORDS-HIGHER Skilled Intentionality for 'Higher' Embodied Cognition: Joining forces with a field of affordances in flux | 2016 | 1˙499˙850.00 | 1˙499˙850.00 |
| 10 | CD40-INN CD40 goes innate: defining and targeting CD40 signaling intermediates in the macrophage to treat atherosclerosis | 2016 | 1˙999˙420.00 | 1˙999˙420.00 |
| 11 | ESCAPE-NET European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment | 2017 | 9˙992˙881.00 | 9˙992˙881.00 |
| 12 | REJUVENATION Repair of Junctional Atrioventricular Conduction and Impulse Formation | 2017 | 1˙499˙995.00 | 1˙499˙995.00 |
| 13 | CTC4BMP Circulating tumor cells for tailoring BMP targeted therapies | 2017 | 150˙000.00 | 150˙000.00 |
| 14 | HYBRIDHEART Development of the first fully biocompatible, soft actuated heart: combining in situ tissue engineering and soft robotics | 2017 | 3˙035˙550.00 | 3˙035˙550.00 |
| 15 | INSIST IN-Silico trials for treatment of acute Ischemic STroke | 2017 | 5˙550˙675.00 | 5˙250˙675.00 |
| 16 | PRODEMOS Prevention of Dementia using Mobile phone Applications | 2018 | 2˙999˙097.00 | 2˙465˙041.00 |
| 17 | PROS-RODAM Hypertension Susceptibility in African Migrants: Solving the puzzle through transcontinental prospective cohort study design | 2018 | 1˙999˙438.00 | 1˙999˙438.00 |
| 18 | MAGIC Magnification of Asthma by human memory Group 2 Innate lymphoid Cells | 2018 | 177˙598.00 | 177˙598.00 |
| 19 | ORGANOVIR Organoids for Virus Research - An innovative training-ETN programme | 2019 | 3˙983˙591.00 | 3˙983˙591.00 |
| 20 | POCON Proof-of-Concept of a nanobody targeting Osteopontin to inhibit colorectal cancer development | 2019 | 149˙953.00 | 149˙953.00 |
| 21 | EBAT Enhancing brown adipose tissue through NAD+ precursors: a new approach to treat cardiometabolic disease | 2019 | 175˙572.00 | 175˙572.00 |
| 22 | NAVIFLU Navigating the evolutionary routes of influenza viruses | 2019 | 1˙999˙331.00 | 1˙999˙331.00 |
| 23 | MDR Structural and functional characterization of MAVS-DDX3-vRNA complex | 2019 | 187˙572.00 | 187˙572.00 |
| 24 | CHANCE Structure guided inhibition of IDOL to treat atherosclerosis and the metabolic syndrome | 2019 | 0.00 | 150˙000.00 |
| 25 | ARCAID Amsterdam Rheumatology Center for AutoImmune Diseases | 2020 | 4˙339˙200.00 | 2˙169˙600.00 |
| 26 | TRACER TRAF-STOP therapy to reduCe inflammation in athERosclerosis. | 2020 | 0.00 | 150˙000.00 |
| 27 | NIMBUS4CIP Effective management of pregnant cancer patients through a cloud-based integrative and highly specialized advisory board platform | 2020 | 0.00 | 150˙000.00 |
| 28 | INDIGO Effective and Affordable Flu Vaccines for the World | 2020 | 16˙000˙968.00 | 9˙975˙979.00 |
| 29 | GONOGO Multi-layered integration of motivated actions and their outcomes in basal ganglia circuits | 2020 | 187˙572.00 | 187˙572.00 |
| 30 | MACROPHAGEEGR Egr1 and Egr2 regulate opposite transcriptional programs in macrophages | 2021 | 175˙572.00 | 175˙572.00 |
More Horizon 2020 projects
The Institution ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM has been involved also in the following Horizon 2020 projects.
- DYNAHEALTH (2015, participant)
- PRECIOUS (2015, participant)
- EPIMAC (2015, participant)
- ECMED (2015, participant)
- COMPARE (2014, participant)
- WOMEN-UP (2015, participant)
- IHEALTH-T2D (2015, participant)
- ASSESS CT (2015, participant)
- EGRET (2015, partner)
- EGRET-PLUS (2016, participant)
- SEPCELL (2015, participant)
- EAVI2020 (2015, participant)
- PERFORM (2016, participant)
- EHVA (2016, participant)
- CRADL (2016, participant)
- MIROR (2016, participant)
- ESA -ITN (2016, participant)
- FOIPO (2017, participant)
- EU-GLIAPHD (2016, participant)
- PRINT-AID (2017, participant)
- FBI (2016, partner)
- GLYSIGN (2016, partner)
- LIVERHOPE (2017, participant)
- HONOURS (2017, participant)
- PIGSS (2017, participant)
- ITCC-P4 (2017, participant)
- META-CAN (2017, participant)
- HEALTHPROS (2018, participant)
- COSMIC (2018, participant)
- LITMUS (2017, participant)
- CURECN (2018, participant)
- SAFECARE (2018, participant)
- NICI (2018, participant)
- PERICO (2018, participant)
- GROWTH (2019, participant)
- DELTASCAN (2018, participant)
- BESTTREAT (2018, participant)
- ASCLEPIOS (2018, participant)
- EJP RD (2019, participant)
- IPC (2019, participant)
- FAIR4HEALTH (2018, participant)
- ECRAID-PLAN (2019, participant)
- BIOMAP (2019, participant)
- 3TR (2019, participant)
- PRECODE (2019, participant)
- QUALITOP (2020, participant)
- CAPABLE (2020, participant)
- RECOGNISED (2020, participant)
- AFFECT-EU (2020, participant)
- FAIR (2020, participant)
- DIAMONDS (2020, participant)
- LONGITOOLS (2020, participant)
- VEO (2020, participant)
- IMMUNOSEP (2020, participant)
- PROFID (2020, participant)
- IMMUNIVERSE (2020, participant)